A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19 – New England Journal of Medicine Commentary on Twitter Another RCT in @NEJM of outpatient treatment with Hydroxychloroquine in high risk folks to prevent COVID transmission No benefit But about 10X rate of adverse events in HCQ group Happy to keep studying HCQ But it […]
The post Cluster-randomized trial: Postexposure hydroxychloroquine does not prevent Covid-19 in healthy persons exposed to a PCR-positive case patient appeared first on Links Medicus.
Assurez-vous d'entrer toutes les informations requises, indiquées par un astérisque (*). Le code HTML n'est pas autorisé.